Theratechnologies (THTX) Expected to Announce Quarterly Earnings on Wednesday

Theratechnologies (NASDAQ:THTXGet Free Report) is expected to be releasing its earnings data before the market opens on Wednesday, February 19th. Analysts expect Theratechnologies to post earnings of $0.05 per share and revenue of $31.86 million for the quarter.

Theratechnologies Stock Performance

Theratechnologies stock opened at $1.62 on Wednesday. The company has a market capitalization of $74.49 million, a price-to-earnings ratio of -16.20 and a beta of 1.26. The company’s 50 day simple moving average is $1.68 and its 200-day simple moving average is $1.42. Theratechnologies has a 1 year low of $1.08 and a 1 year high of $2.18.

About Theratechnologies

(Get Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.

Recommended Stories

Earnings History for Theratechnologies (NASDAQ:THTX)

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.